Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Identify effective ways to increase income to pay off debt. Maximize your earnings and take control of your financial future.
22,636 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Institutional moves can reveal much about a company’s future. This article breaks down why long path partners buys Al...
EWY has surged in 2026 on AI-driven demand for memory chips, attracting a growing cohort of retirees into the play. T...
Facing market volatility, savvy investors turn to durable brands. Here are two consumer staples stocks right now that...
Geopolitical tensions and stubborn inflation are rattling markets. Even higher-income americans turning cautious sign...
The NEOS QQQI ETF offers a high monthly yield, but hidden costs could erode capital in calmer markets. This report ex...
Apple's dependable cash flow and dividends meet a challenging, transforming Tesla. As 2026 unfolds, investors weigh w...
As 2026 unfolds, REITs offer liquidity and steady income in a rate-sensitive environment. This report highlights the ...
A 2026 market backdrop prompts a fresh look at when to retire early. A saver chasing seven figures weighs the 4% rule...
Cash flow from senior housing and warehouse REITs is holding steady even as refinancing costs rise. The payout outloo...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Looking for steady income and growth over the next ten years? These three dividend stocks hold next decade potential ...